167 related articles for article (PubMed ID: 8766531)
1. Effect of circulating antigen on immunoscintigraphy of ovarian cancer patients using anti-CA125 monoclonal antibody.
Sakahara H; Hosono M; Kobayashi H; Yao Z; Saga T; Yano S; Endo K; Mori T; Konishi J
Jpn J Cancer Res; 1996 Jun; 87(6):655-61. PubMed ID: 8766531
[TBL] [Abstract][Full Text] [Related]
2. Clinical immunoscintigraphy of ovarian carcinoma using iodine-131-labeled 145-9 monoclonal antibody.
Chung JK; Kang SB; Lee HP; Lee MC; Koh CS; Sakahara H; Endo K
J Nucl Med; 1993 Oct; 34(10):1651-5. PubMed ID: 8410277
[TBL] [Abstract][Full Text] [Related]
3. Induction of CA125-specific B and T cell responses in patients injected with MAb-B43.13--evidence for antibody-mediated antigen-processing and presentation of CA125 in vivo.
Noujaim AA; Schultes BC; Baum RP; Madiyalakan R
Cancer Biother Radiopharm; 2001 Jun; 16(3):187-203. PubMed ID: 11471484
[TBL] [Abstract][Full Text] [Related]
4. Antibody-antigen complex formation following injection of OC125 monoclonal antibody in patients with ovarian cancer.
Haisma HJ; Battaile A; Stradtman EW; Knapp RC; Zurawski VR
Int J Cancer; 1987 Dec; 40(6):758-62. PubMed ID: 3480271
[TBL] [Abstract][Full Text] [Related]
5. Anti-murine antibody response to mouse monoclonal antibodies in cancer patients.
Sakahara H; Saga T; Onodera H; Yao Z; Nakamoto Y; Zhang M; Sato N; Nakada H; Yamashina I; Endo K; Konishi J
Jpn J Cancer Res; 1997 Sep; 88(9):895-9. PubMed ID: 9369938
[TBL] [Abstract][Full Text] [Related]
6. Distribution of radiolabelled anti-CA125 monoclonal antibody OC125-F(ab)2-fragment following resection guided by antibodies (REGAJ) in ovarian cancer patients.
Uttenreuther-Fischer MM; Feistel H; Wolf F; Jäger W
J Clin Lab Anal; 1997; 11(2):94-103. PubMed ID: 9058243
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the diagnostic usefulness of CA125 immunoscintigraphy for ovarian carcinoma follow-up after treatment: contribution of this technique in Grenoble University Medical Center].
Vuillez JP; Levrot E; Mousseau M; Buffaz PD; Bolla M; Payan R; Comet M; Schaerer R
Bull Cancer; 1997 Nov; 84(11):1033-42. PubMed ID: 9536985
[TBL] [Abstract][Full Text] [Related]
8. [Basic study for immunoscintigraphy of ovarian cancer using 99mTc labeled F(ab')2 fragments of monoclonal antibody].
Sugiyama S
Kaku Igaku; 1994 Apr; 31(4):327-36. PubMed ID: 8196229
[TBL] [Abstract][Full Text] [Related]
9. The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody.
Davidson BR; Babich J; Young H; Waddington W; Clarke G; Short M; Boulos P; Styles J; Dean C
Br J Cancer; 1991 Nov; 64(5):850-6. PubMed ID: 1931605
[TBL] [Abstract][Full Text] [Related]
10. CA125 immune complexes in ovarian cancer patients with low CA125 concentrations.
Cramer DW; O'Rourke DJ; Vitonis AF; Matulonis UA; Dijohnson DA; Sluss PM; Crum CP; Liu BC
Clin Chem; 2010 Dec; 56(12):1889-92. PubMed ID: 20943848
[TBL] [Abstract][Full Text] [Related]
11. Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis.
Sharma SK; Sevak KK; Monette S; Carlin SD; Knight JC; Wuest FR; Sala E; Zeglis BM; Lewis JS
J Nucl Med; 2016 May; 57(5):771-6. PubMed ID: 26837339
[TBL] [Abstract][Full Text] [Related]
12. A human/mouse chimeric monoclonal antibody against CA125 for radioimmunoimaging of ovarian cancer.
Kobayashi H; Sakahara H; Saga T; Hosono M; Shirato M; Kanda H; Ishibashi K; Watanabe T; Endo K; Ishiwata I
Cancer Immunol Immunother; 1993 Aug; 37(3):143-9. PubMed ID: 7687520
[TBL] [Abstract][Full Text] [Related]
13. [Radioimmunoimaging assay of ovarian tumor with 99mTc labeled anti-carcinoembryonic antigen monoclonal antibody].
Wu LY; Wu AR; Zhan J
Zhonghua Fu Chan Ke Za Zhi; 1994 Jun; 29(6):340-2, 381-2. PubMed ID: 8001407
[TBL] [Abstract][Full Text] [Related]
14. Clinical assessment of 111In-CYT-103 immunoscintigraphy in ovarian cancer.
Surwit EA; Childers JM; Krag DN; Katterhagen JG; Gallion HH; Waggoner S; Mann WJ
Gynecol Oncol; 1993 Mar; 48(3):285-92. PubMed ID: 8462896
[TBL] [Abstract][Full Text] [Related]
15. OC125 immunoscintigraphy in ovarian carcinoma: a comparison with alternative methods of assessment.
Maughan TS; Haylock B; Hayward M; Facey P; Evans WD; Shelley MD; Fish RG; Adams M
Clin Oncol (R Coll Radiol); 1990 Jul; 2(4):199-205. PubMed ID: 2261415
[TBL] [Abstract][Full Text] [Related]
16. Immunological responses to the tumor-associated antigen CA125 in patients with advanced ovarian cancer induced by the murine monoclonal anti-idiotype vaccine ACA125.
Wagner U; Schlebusch H; Köhler S; Schmolling J; Grünn U; Krebs D
Hybridoma; 1997 Feb; 16(1):33-40. PubMed ID: 9085126
[TBL] [Abstract][Full Text] [Related]
17. IMMULITE OM-MA assay: a useful diagnostic tool in patients with benign and malignant ovarian tumors.
Gebauer G; Rieger M; Jäger W; Lang N
Anticancer Res; 1999; 19(4A):2535-6. PubMed ID: 10470190
[TBL] [Abstract][Full Text] [Related]
18. Human monoclonal antibody for ovarian clear cell carcinoma-2, a human monoclonal antibody with antitumor activity against ovarian cancer cells that recognizes CA125-like antigen.
Suzuki N; Tamada Y; Shigirahara K; Suzuki A; Susumu N; Ishida I; Aoki D
Int J Gynecol Cancer; 2008; 18(5):996-1006. PubMed ID: 18028379
[TBL] [Abstract][Full Text] [Related]
19. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
[TBL] [Abstract][Full Text] [Related]
20. Daunorubicin conjugated to a monoclonal anti-CA125 antibody selectively kills human ovarian cancer cells.
Sweet F; Rosik LO; Sommers GM; Collins JL
Gynecol Oncol; 1989 Sep; 34(3):305-11. PubMed ID: 2788601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]